Pulse Biosciences, Inc. (PLSE) financial statements and ratios from SEC XBRL: revenue $350000.00 (TTM), net margin -20794.6%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $350000.00 |
| Net Margin | -20794.6% |
| Price / Book | 34.34 |
| Price / Sales | 2277.81 |
| FCF Yield | -2.3% |
| Altman Z-Score | 132.67 (safe) |
| Sector P/E (Healthcare) | 21.6 |
PLSE overview · PLSE earnings · PLSE KPIs · PLSE investor relations · PLSE ownership · PLSE peers · PLSE filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.